SA

Sunil Ambawat

Director Director DIN 08972203
DIN 08972203 First appointment Nov 2020 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Nov 2020
Shareholding value Locked Premium profile

About Sunil Ambawat

Data last updated:

Sunil Ambawat has 5 years in corporate governance. Formerly with 1 company, such as Rathod Pharmachem Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08972203
Primary Designation Director
First Appointment 06 Nov 2020
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Rathod Pharmachem Private Limited U24230GJ2020PTC111937
Director06 Nov 20202020Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rathod Pharmachem Private Limited
Premium access

Shareholding and investment profile for Sunil Ambawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Ambawat

Sunil Ambawat has 5 years in corporate governance. Formerly with 1 company, such as Rathod Pharmachem Private Limited. Engaged in General Business. Contributes to corporate operations.

Sunil Ambawat is associated with 0 companies as a director.

Sunil Ambawat has expertise in General Business.

Sunil Ambawat has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available